Previous Section
General Interest Articles
21. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.
- Author
- Steensma DP; Heptinstall KV; Johnson VM; Novotny PJ; Sloan JA; Camoriano JK; Niblack J; Bennett JM; Mesa RA;
- Institution
- Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. steensma.david@mayo.edu
- Journal
- Leuk Res. 2008 May;32(5):691-8. Epub 2007 Dec 4.
- Abstract URL
- Click here to view abstract
22. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
- Author
- Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A;
- Institution
- Division of Hematology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
- Journal
- Leuk Res. 2008 Mar;32(3):407-11. Epub 2007 Aug 20.
- Abstract URL
- Click here to view abstract
23. Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapy.
- Author
- Czuczman MS; Emmanouilides C; Darif M; Witzig TE; Gordon LI; Revell S; Vo K; Molina A;
- Institution
- Roswell Park Cancer Institute, Buffalo, NY 14263, USA. myron.czuczman@roswellpark.org
- Journal
- J Clin Oncol. 2007 Sep 20;25(27):4285-92. Epub 2007 Aug 20.
- Abstract URL
- Click here to view abstract
24. Rare t(1;11)(q23;p15) in therapy-related myelodysplastic syndrome evolving into acute myelomonocytic leukemia: a case report and review of the literature.
- Author
- Zhang L; Alsabeh R; Mecucci C; La Starza R; Gorello P; Lee S; Lill M; Schreck R;
- Institution
- Department of Pathology and Laboratory, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Room 4711, Los Angeles, CA 90048, USA. zhang11999@yahoo.com
- Journal
- Cancer Genet Cytogenet. 2007 Oct 1;178(1):42-8.
- Abstract URL
- Click here to view abstract
25. Skin cancer after nonmyeloablative hematopoietic cell transplantation.
- Author
- Cavalier M; Shmalo JA; Yu M; Billings SD; Abonour R; Nelson RP Jr;
- Institution
- Department of Pediatric Hematology/Oncology, Indiana University School of Medicine, 535 Barnhill Drive, Indianapolis, IN 46202, USA.
- Journal
- Bone Marrow Transplant. 2006 Jun;37(12):1103-8.
- Abstract URL
- Click here to view abstract
26. Myelodysplastic syndromes clinical practice guidelines in oncology.
- Author
- Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS; Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS;
- Institution
- Stanford Hospital and Clinics, Stanford, CA, USA.
- Journal
- J Natl Compr Canc Netw. 2006 Jan;4(1):58-77.
27. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
- Author
- Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR; Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR;
- Institution
- Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. dlh23@columbia.edu
- Journal
- J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.
- Abstract URL
- Click here to view abstract
28. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
- Author
- Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstocker M; Ruter B; Sperr WR; Stauder R; Wells DA; Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstocker M; Ruter B; Sperr WR; Stauder R; Wells DA;
- Institution
- Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. peter.valent@meduniwien.ac.at
- Journal
- Leuk Res. 2007 Jun;31(6):727-36. Epub 2007 Jan 25.
- Abstract URL
- Click here to view abstract
29. A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
- Author
- Sekeres MA; Fu AZ; Maciejewski JP; Golshayan AR; Kalaycio ME; Kattan MW;
- Institution
- Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio 44195, USA. sekerem@ccf.org
- Journal
- Cancer. 2007 Mar 15;109(6):1125-32.
- Abstract URL
- Click here to view abstract
30. Myelodysplastic and myeloproliferative disorders in children.
- Author
- Hasle H;
- Institution
- Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark. Hasle@dadlnet.dk
- Journal
- Curr Opin Pediatr. 2007 Feb;19(1):1-8.
- Abstract URL
- Click here to view abstract
Next: Drug Therapy
